Galectin-3 induces endothetial cell morphogenesis and angiogenesis

Citation
P. Nangia-makker et al., Galectin-3 induces endothetial cell morphogenesis and angiogenesis, AM J PATH, 156(3), 2000, pp. 899-909
Citations number
66
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
AMERICAN JOURNAL OF PATHOLOGY
ISSN journal
00029440 → ACNP
Volume
156
Issue
3
Year of publication
2000
Pages
899 - 909
Database
ISI
SICI code
0002-9440(200003)156:3<899:GIECMA>2.0.ZU;2-C
Abstract
Increasing evidence suggests that carbohydrate-binding proteins play an ess ential role in tumor growth and metastasis. However, conflicting results on their function in the regulation of cell proliferation and differentiation during angiogenesis have been reported. We have examined the role of galec tin-3 in the regulation of human umbilical vein endothelial cell proliferat ion, differentiation, migration, and neovascularization. Galectin-3, a carb ohydrate-binding protein, with specificity for type 1 and 11 ABH blood grou p epitopes and polylactosamine glycan containing cell surface glycoproteins , is the major nonintegrin-cellular laminin-binding protein. Because galect in-3 expression was shown to be associated in some tumor systems with metas tasis, we questioned whether it induces endothelial cell morphogenesis. Her e we show that galectin-3 affects chemotaxis and morphology and stimulates capillary tube formation of HUV-EC-C in vitro and angiogenesis in vivo. End othelial cell morphogenesis is a carbohydrate-dependent process, as it is n eutralized by specific sugars and antibodies. These findings demonstrate th at endothelial cell surface carbohydrate recognition event(s) can induce a signaling cascade leading to the differentiation and angiogenesis of endoth elial cells.